What information is required on each line of the DEA 222 form when checking in controlled substances?

The requirement for including the date and quantity of medication received on each line of the DEA 222 form is crucial for maintaining accurate records of controlled substances. This form is utilized for the transfer of Schedule I and II controlled substances between registrants and is fundamental in tracking the movement of these high-potency medications.

By documenting the date, the pharmacy indicates when the controlled substances were actually received, which helps establish a timeline of inventory management. Additionally, recording the quantity of medication received ensures that there is a clear and transparent account of how much of each controlled substance has been transferred, thereby preventing discrepancies and potential misuse. This process is essential for compliance with federal regulations that govern the handling and distribution of controlled substances.

The other options involve information that is not part of the specific requirements for the DEA 222 form. The prescriber's information, patient's details, or just pharmacist initials do not fulfill the necessary documentation needed on this particular form when it comes to checking in controlled substances. Such specifics pertain to different forms or record-keeping processes rather than the DEA 222 form itself.